Andrew Joseph covers health, medicine, and the biopharma industest in Europe. You can reach Andrew on Signal at drewqjoseph.71. ROME…
Read More
Basecamp Research unveils programmable gene insertion AI models, as confirms Nvidia investment
A UK startup aiming to solve key challenges in life sciences through AI has unveiled the “world’s first AI models…
Read More
Vivek Ramaswamy’s brother Shankar raises $1.2 billion for gene therapy firm with no successful results: ‘Another pump-and-dump’
Kriya Therapeutics, a gene therapy company founded in 2019 by Shankar Ramaswamy, brother of GOP leader Vivek Ramaswamy, has raised…
Read More
Gene therapy for severe epilepsy relocates forward with EpilepsyGTx’s €28 million funding
EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More
Vietnam’s Gene Solutions seeks $100 million from pre-IPO and 2026 listing
By Phuong Nguyen and Yantoultra Ngui HANOI/SINGAPORE (Reuters) -Vietnam-founded biotechnology firm Gene Solutions plans to raise $100 million through a…
Read More
Vietnam’s Gene Solutions seeks $100 million from pre-IPO and 2026 listing | 1450 AM 99.7 FM WHTC
Vietnam’s Gene Solutions seeks $100 million from pre-IPO and 2026 listing | 1450 AM 99.7 FM WHTC | Holland …
Read More
Vietnam’s Gene Solutions seeks $100 million from pre-IPO and 2026 listing
By Phuong Nguyen and Yantoultra Ngui HANOI/SINGAPORE (Reuters) -Vietnam-founded biotechnology firm Gene Solutions plans to raise $100 million through a…
Read More
Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock
Company & Focus: UniQure N.V. is a Dutch-American biotechnology company (NASDAQ: QURE) specializing in gene therapies. It developed the first…
Read More
Europe relocates to reject embattled Duchenne gene therapy
Andrew Joseph covers health, medicine, and the biopharma indusattempt in Europe. You can reach Andrew on Signal at drewqjoseph.45. European…
Read More
London-based beginup Laverock Therapeutics raises over €23.3 million for its gene control tech
British HealthTech beginup Laverock Therapeutics, a gene control company focapplyd on the development of disease-responsive advanced therapies, announced the expansion…
Read More
